In another study involving more than 96,000 patients initiating GLP-1s, 46% of patients with and 65% without Type 2 diabetes discontinued the drugs within one year
Dushay cited hopes that pill versions of GLP-1 drugs could ease shortages, come at lower cost and enhance convenience
This leads many people to prematurely conclude that retatrutide is not working when, in fact, it is working exactly as designed
doi: 10.1152/physrev.00049.2019 77 PathakPLiuHBoehmeSXieCKrauszKWGonzalezFet al
For patients with Hashimoto's disease considering GLP-1 receptor agonist therapy for appropriate metabolic indications, several safety considerations warrant careful attention
"I'm not even sure everyone can trace back where the drugs are being made," he says